Clinical Trials Browser

Phase 4 × Uterine Cervical Neoplasms × 90 days × Clear all

Urogenital Diseases, Uterine Cervical Diseases, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Female Urogenital Diseases

NCT05334706 2026-02-23

RIFT-HPV

Phase 4 Recruiting

69 enrolled

Gynecologic

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT07412873 2026-02-17

PROVIDENCE

Phase 4 Not yet recruiting

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06786429 2026-01-21

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Phase 4 Not yet recruiting

1,800 enrolled

GastrointestinalGynecologic

Anxiety Disorders, Uterine Cervical Neoplasms, Depression, Hepatitis B, Carcinoma, Hepatocellular, Gallstones

Clinical Trials

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

RIFT-HPV

PROVIDENCE

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.